Table 1.
Comparison of Reviewed Versus Nonreviewed Cases by Selected Demographics and Clinical Characteristics
| Reviewed (n = 370) n (%) | Not reviewed (n = 691) n (%) | p | |
|---|---|---|---|
| Age at diagnosis | <0.01 | ||
| 0–4 | 88 (23.8) | 149 (21.6) | |
| 5–9 | 95 (25.7) | 133 (19.2) | |
| 10–15 | 107 (28.9) | 173 (25.0) | |
| 16–21 | 80 (21.6) | 236 (34.2) | |
| Gender | 0.060 | ||
| Male | 193 (52.2) | 402 (58.2) | |
| Female | 177 (47.8) | 289 (41.9) | |
| Race | 0.370 | ||
| White | 330 (89.2) | 630 (91.2) | |
| Black | 29 (7.8) | 49 (7.1) | |
| Other | 11 (3.0) | 12 (1.7) | |
| Malignancy | 0.032 | ||
| Leukemia | 115 (31.1) | 166 (24.0) | |
| Lymphoma | 118 (31.9) | 205 (29.7) | |
| CNS | 25 (6.8) | 54 (7.8) | |
| Sarcoma | 57 (15.4) | 122 (17.7) | |
| Other | 55 (14.9) | 144 (20.8) | |
| Decade of diagnosis | 0.225 | ||
| 1960/1970s | 89 (24.1) | 190 (27.5) | |
| 1980s | 95 (25.7) | 196 (28.4) | |
| 1990s | 107 (28.9) | 164 (23.7) | |
| 2000s | 79 (21.4) | 141 (20.4) |
CNS, central nervous system.